
Glenview Capital Management, LLC
About Glenview Capital Management, LLC’s 13F portfolio
Glenview Capital Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Glenview Capital Management, LLC reported $5.0B across 42 US-listed positions (). Its largest position is GLOBAL PMTS INC (GPN) at 13% of the reported book, and its ten biggest holdings make up 64% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE: GPN GLOBAL PMTS INC | $83.52 −2.45% | 13% | 8.9M | $646.3M |
| 2 | NYSE: CVS CVS HEALTH CORP | $80.04 −1.61% | 10.0% | 4.8M | $499.1M |
| 3 | NYSE: THC TENET HEALTHCARE CORP | $263.59 −2.86% | 8.4% | 2.2M | $418.2M |
| 4 | NYSE: TMO THERMO FISHER SCIENTIFIC INC | $688.75 −0.58% | 6.3% | 627K | $314.5M |
| 5 | NASDAQ: AMZN AMAZON COM INC | $257.37 −3.87% | 6.1% | 1.3M | $303.1M |
| 6 | NYSE: A AGILENT TECHNOLOGIES INC | $175.34 −1.12% | 5.2% | 2.0M | $261.6M |
| 7 | NYSE: DHR DANAHER CORP DEL | $227.56 −0.45% | 4.4% | 1.1M | $218.3M |
| 8 | NASDAQ: META META PLATFORMS INC | $596.22 −3.27% | 4.0% | 357K | $201.0M |
| 9 | NASDAQ: AMD ADVANCED MICRO DEVICES INC | $489.19 −7.72% | 3.5% | 298K | $173.3M |
| 10 | NYSE: TEVA TEVA PHARMACEUTICAL INDS LTD | $38.54 −8.74% | 3.4% | 5.1M | $172.1M |
| 11 | NASDAQ: VTRS VIATRIS INC | $19.88 −1.97% | 3.1% | 9.9M | $156.9M |
| 12 | NYSE: UBER UBER TECHNOLOGIES INC | $65.60 −4.60% | 2.6% | 1.8M | $129.4M |
| 13 | NYSE: CNC CENTENE CORP DEL | $65.58 −2.77% | 2.4% | 1.9M | $121.1M |
| 14 | NYSE: BFLY BUTTERFLY NETWORK INC | $5.85 −3.78% | 2.4% | 14.3M | $120.7M |
| 15 | NYSE: CI THE CIGNA GROUP | $273.04 −4.32% | 2.3% | 412K | $113.6M |
| 16 | NYSE: HUM HUMANA INC | $380.00 −1.50% | 2.0% | 254K | $101.0M |
| 17 | OTC: BSQKZ BLOCK INC | $84.51 0.00% | 1.8% | 1.2M | $91.0M |
| 18 | NYSE: DKS DICKS SPORTING GOODS INC | $136.14 −5.91% | 1.8% | 401K | $91.0M |
| 19 | NYSE: GENI GENIUS SPORTS LIMITED | $5.82 −4.75% | 1.6% | 13.5M | $81.8M |
| 20 | NYSE: ONTO ONTO INNOVATION INC | $195.93 −2.53% | 1.6% | 206K | $77.9M |
| 21 | NYSE: LLY ELI LILLY & CO | $1,351.12 −2.29% | 1.4% | 58K | $69.3M |
| 22 | NASDAQ: UAL UNITED AIRLS HLDGS INC | $105.53 −1.95% | 1.3% | 495K | $67.3M |
| 23 | NASDAQ: EYE NATIONAL VISION HLDGS INC | $17.01 −3.35% | 1.2% | 3.1M | $59.0M |
| 24 | NASDAQ: CSCO CISCO SYS INC | $94.70 −2.55% | 1.0% | 413K | $48.5M |
| 25 | NYSE: ESI ELEMENT SOLUTIONS INC | $32.03 −1.66% | 0.9% | 995K | $47.5M |
Showing 1–25 of 42 positions on this page reported in this 13F.
- Healthcare54%
- Industrials14%
- Technology12%
- Consumer Cyclical9.9%
- Communication Services5.6%
- Basic Materials0.9%
- Energy0.5%
- Consumer Defensive0.2%
- AddedGPNGLOBAL PMTS INC+40.0%$646.3M
- AddedTHCTENET HEALTHCARE CORP+46.6%$418.2M
- AddedTMOTHERMO FISHER SCIENTIFIC INC+150%$314.5M
- AddedAMZNAMAZON COM INC+20.1%$303.1M
- NewAAGILENT TECHNOLOGIES INC—$261.6M
- AddedDHRDANAHER CORP DEL+633%$218.3M
- AddedMETAMETA PLATFORMS INC+191%$201.0M
- AddedVTRSVIATRIS INC+8.7%$156.9M
- AddedUBERUBER TECHNOLOGIES INC+23.2%$129.4M
- AddedDKSDICKS SPORTING GOODS INC+34.2%$91.0M
- ReducedCVSCVS HEALTH CORP−41.1%$499.1M
- ReducedAMDADVANCED MICRO DEVICES INC−54.1%$173.3M
- ReducedTEVATEVA PHARMACEUTICAL INDS LTD−23.7%$172.1M
- ReducedCNCCENTENE CORP DEL−41.3%$121.1M
- ReducedCITHE CIGNA GROUP−17.4%$113.6M
- ReducedHUMHUMANA INC−24.1%$101.0M
- ReducedBSQKZBLOCK INC−12.3%$91.0M
- ReducedONTOONTO INNOVATION INC−31.3%$77.9M
- ReducedUALUNITED AIRLS HLDGS INC−0.4%$67.3M
- ReducedESIELEMENT SOLUTIONS INC−38.9%$47.5M
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | BFLY Butterfly Network, Inc. | 13D | 8.5% · 2 classes | 19.3M | Filed 17 FEB 2026 |
| 2 | GENI Genius Sports Ltd | 13G | 6.2% | 16.6M | Filed 16 NOV 2026 |
| 3 | SGRY Surgery Partners, Inc. | 13G | 5.4% | 7.0M | Filed 13 OCT 2026 |
| 4 | GTM ZoomInfo Technologies Inc. | 13G | 5.3% | 17.6M | Filed 11 JUL 2025 |
| 5 | MYGN MYRIAD GENETICS INC | 13G | 5.3% | 4.9M | Filed 13 JAN 2026 |
Showing all 5 disclosed stakes. 1 last disclosed over a year ago (the holder may since have dropped below 5%).
Reading Glenview Capital Management, LLC’s 13F portfolio
Glenview Capital Management, LLC’s $5.0B 13F book is spread across 42 reported positions and is highly concentrated — its ten largest positions alone are 64% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are GPN, CVS, THC, TMO and AMZN, led by GLOBAL PMTS INC (GPN) at 13% of the portfolio. The heaviest sector exposure is Healthcare (54%), then Industrials (14%).
What Glenview Capital Management, LLC changed last quarter
Between 2026-03-31 and Q2 2026, Glenview Capital Management, LLC was roughly balanced between buying and selling: it opened 12 new positions and added to 14 more, while trimming 15 and closing 11 outright. Against a 42-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was GLOBAL PMTS INC (GPN), and its biggest reduction was CVS HEALTH CORP (CVS).
What a 13F does and doesn’t reveal
A 13F captures only Glenview Capital Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Glenview Capital Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Glenview Capital Management, LLC's profile on this page is built directly from those filings.
How current is the 13F data on Glenview Capital Management, LLC's page?
It reflects Glenview Capital Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Glenview Capital Management, LLC files its next quarterly report, this page refreshes automatically.
Can I see Glenview Capital Management, LLC's complete list of holdings?
This page highlights Glenview Capital Management, LLC's largest positions rather than all 42 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Glenview Capital Management, LLC's filings.
Does a 13F show everything Glenview Capital Management, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Glenview Capital Management, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Glenview Capital Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

